A new experimental antibiotic for tuberculosis has been shown to be more effective against TB than isoniazid, a decades-old drug which is currently one of the standard treatments. In mouse studies, the new drug showed a much ...
Feb 11, 2019
0
2
Researchers at Johns Hopkins Medicine say they have added to evidence that rapid resistance gene sequencing technology can accurately speed the identification of specific antibiotic-resistant bacteria strains that sicken ...
Jan 17, 2019
0
0
A team of investigators from the University of Pittsburgh has identified compounds that block the reactivation of latent HIV-1 in a human cell line containing the latent virus. The research is published December 3rd in Antimicrobial ...
Dec 3, 2018
0
5
Multidrug-resistant bacterial infections of the cornea are a leading cause of blindness and cannot be effectively managed with current ophthalmic antibiotics. A team of investigators has now devised a combination therapy ...
Nov 12, 2018
0
7
Sepsis is a major cause of preventable death among newborn children in tropical countries. Now the antibiotic ceftriaxone, which has been available only as an injectable, can be administered through rectal delivery. This ...
Oct 22, 2018
0
0
Bacteria—especially Gram-negative strains—are becoming increasingly resistant to current antibiotic drugs, and the development of new classes of antibiotics has slowed. Faced with these challenges, investigators are studying ...
Aug 10, 2018
0
3
To determine which antibiotics reliably treat which bacterial infections, diagnostic laboratories that focus on clinical microbiology test pathogens isolated from patients. As multidrug-resistant organisms continue to emerge, ...
Jul 6, 2018
0
0
Inappropriate antibiotic prescribing is rampant at primary care clinics within the Veterans Administration (VA) healthcare system in Pittsburgh, despite the rise of antibiotic resistance. About half of all prescriptions reviewed ...
Jul 2, 2018
0
1
Research carried out by St George's, University of London into tuberculosis treatments has clearly shown the 'persistent bacteria' that make treating the disease so difficult for the first time, using a new combination therapy.
Jun 1, 2018
0
1
A common antibacterial substance found in toothpaste may combat life-threatening diseases such as cystic fibrosis, or CF, when combined with an already FDA-approved drug.
May 17, 2018
0
16
